Delivery Order SPE2DB25D3109-SPE2DB25FPLAQ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Telmisartan-Amlodipine 40-5 mg tablets (30-count) with a ceiling value of $1,101.71. This competitively awarded, firm fixed-price delivery order represents a continuation of the company's ongoing pharmaceutical supply relationship with DLA and is not designated as a set-aside contract. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supply, specifically Telmisartan-Amlodipine 40-5 mg tablets (30-count), valued at $1,426.32. The award was made on October 22, 2025, with an ultimate completion date of October 23, 2025, utilizing firm fixed-price pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location, serving as...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 19, 2025, by the Defense Logistics Agency for the supply of Telmisartan-Amlodipine 40-5 mg tablets (30-count) with a ceiling value of $2,273.46. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $4,639.13 to AmerisourceBergen Drug Corp for Telmisartan-Amlodipine 40-5 mg tablets (30-count supply) on August 27, 2025, with a completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a single shipment of a combination antihypertensive medication to...
- The Defense Logistics Agency awarded a delivery order valued at $1,541.90 to AmerisourceBergen Drug Corp for Telmisartan-Amlodipine 40-5 mg tablets (30-count supply) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-Amlodipine 40-5 mg tablets (30-count supply) on March 5, 2025, with a ceiling value of $2,115.16. This non-competitive, firm fixed price delivery order is set to be completed by March 6, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order falls...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Telmisartan-Amlodipine 40-5 mg tablets in a 30-count package. This competitively awarded, firm fixed-price delivery order has a ceiling value of $3,017.64 and is scheduled for completion by August 13, 2025. The contract is unsolicited for set-aside programs and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,008.72 to AmerisourceBergen Drug Corp for the supply of Telmisartan-Amlodipine 80-5 mg tablets (30-count units). This competitive, firm fixed-price delivery order was issued on September 25, 2025, with an ultimate completion date of September 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-Amlodipine 40-5 mg tablets (30-count) on August 12, 2025, with a ceiling value of $1,344.82 and ultimate completion date of August 13, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for Telmisartan-Amlodipine 40-5 mg tablets (30-count supply) with a ceiling value of $1,848.27. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 12, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating full open competition among qualified...
- SPE2DB25D3109Indefinite Delivery Contract
- SPE2DB25D3109-SPE2DB25FPLAQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-Amlodipine 40-5 mg tablets (30-count supply) with a ceiling value of $1,939.39. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, completed on August 27, 2025. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to military healthcare programs worldwide. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen regularly fulfills federal medical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitively awarded contracts demonstrating the company's capability to meet federal specifications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/26/25 |